No Result
View All Result
Thursday, November 19, 2026
MM News
اردو
  • Home
  • Latest News
  • National
  • Crime
  • Opinions
  • The Other Side
MM News
  • Home
  • Latest News
  • National
  • Crime
  • Opinions
  • The Other Side
No Result
View All Result
No Result
View All Result
MM News
اردو
  • Latest
  • National
  • Crime
  • Opinions
  • The Other Side-Pakistan
Home Uncategorized

J&J to stop selling opioids in US, reaches $230mn settlement

MM News Staff by MM News Staff
June 28, 2021
Reading Time: 3 mins read
Johnson & Johnson is one pharmaceutical giants accused of fueling the deadly US opioid crisis. Source: VOX

Johnson & Johnson is one pharmaceutical giants accused of fueling the deadly US opioid crisis. Source: VOX

NEW YORK: Johnson & Johnson, one of the pharmaceutical giants accused of fueling the deadly US opioid crisis, has reached a settlement with the state of New York for $230 million and confirmed it will stop making or selling opioids in the United States.

The agreement allows Johnson & Johnson to resolve litigation over its role in the epidemic, which has killed more than half a million people since 1999, according to a statement from New York attorney general Letitia James.

In a separate statement, J&J said the settlement allowed it to avoid a trial that was scheduled to begin on Monday, and said the group had “made the business decision in 2020 to discontinue all of its prescription pain medications in the United States.”

ADVERTISEMENT

“The settlement “is not an admission of liability or wrongdoing by the company,” it said, noting that other nationwide legal proceedings are underway including a trial in California. The prosecutor’s statement said the company would spread the payments over nine years. J&J could also pay an additional $30 million in the first year if the state enacts new legislation creating an opioid settlement fund.

“The opioid epidemic has wreaked havoc on countless communities across New York and the rest of the nation, leaving millions still addicted to dangerous and deadly opioids,” James said in the statement. “Johnson & Johnson helped fuel this fire, but today they’re committing to leaving the opioid business — not only in New York, but across the entire country,” she added.

That includes both manufacturing and selling opioids, James’ statement said. Johnson & Johnson stressed it had made the decision before the settlement was reached. The $230 million will be aimed at prevention, treatment and education efforts on the dangers of the substances in New York state.

READ MORE  US approves J&J Covid vaccine for emergency use

Johnson & Johnson, Purdue Pharma and other pharmaceutical companies and distributors are accused of encouraging doctors to overprescribe opioids — initially reserved for patients with particularly serious cancers — even though they knew they were highly addictive.

Since 1999, this dependence has pushed many users of the drugs to higher and higher doses and to illicit substances such as heroin or fentanyl, an extremely powerful synthetic opiate with a high risk of fatal overdose.  About 500,000 people have died of drug overdoses in the United States since then.

The US Centre for Disease Control and Prevention, the country’s main public health agency, estimates that about 90,000 people died from drug overdoses in 2020, the majority of which involved opioids.

The US Department of Health estimates that the crisis was responsible for four years of declining life expectancy in 2014, 2015, 2016 and 2017.  Then-president Donald Trump declared it a national public health emergency in October 2017.

READ MORE: US halts use of J&J vaccine over rare blood clots

The CDC estimated in 2019 that the economic burden of the crisis, including health care costs, lost productivity and costs to the criminal justice system, was about $78.5 billion per year. A study published by the American Society of Actuaries estimated the cost for the four years 2015-2018 at $631 billion.

The crisis seemed to be easing before the pandemic in particular due to tighter controls on prescriptions, but the CDC recently reported an acceleration of deaths from drug overdoses including from opioids.

While legal proceedings have increased in the country, many companies are trying to reach settlements.  In February, the consulting firm McKinsey said it agreed to pay $573 million to settle lawsuits filed by some 40 US states accusing it of contributing to the opioid crisis through its advice to pharmaceutical companies, including Purdue Pharma, the manufacturer of Oxycontin.

Tags: Johnson & JohnsonopiodsUSA
ShareTweetSendShare
Previous Post

Serena Williams decides to skip Tokyo Olympics

Next Post

Why is our economy fragile since 72 years?

Related Stories

Uncategorized

Emergency at Tarbela Hydropower Project as Water Enters Tunnel Construction Area

November 9, 2026
Photo, online
Uncategorized

Riyadh Air Suspends Flights from Riyadh Until November 7, Operations Shift to Qassim

October 25, 2026
File photo
Uncategorized

Tiger Shroff Case: Suspects Surveyed Salman & Amitabh’s Homes

October 22, 2026
File
Uncategorized

Petrol at Rs387, Diesel at Rs397 per Litre! When Will the Shehbaz Government Give Relief to the Public?

October 17, 2026
Next Post

Why is our economy fragile since 72 years?

Latest

Bilawal Questions Pakistan’s System, But Who Will Question PPP’s 18-Year Rule in Sindh?

15 hours ago

Pakistani National or Iranian Agent? Man Behind Alleged Trump Assassination Plot Gets 27 Years

15 hours ago

Pakistani Group Acquires US Consul General’s Residence in Karachi for Rs6.92 Billion

16 hours ago

Gold Prices Crash to Lowest Level Since Sep 2025; Silver and Platinum Also Slide

17 hours ago

Middle East Tensions Fail to Stop Oil Price Decline as Brent Slips to $92.98

17 hours ago

Pakistan Forex Rates Today: Dollar, Pound, Euro and Riyal Prices Revealed

17 hours ago

Will Your Area Face a Power Cut on November 18? K-Electric Releases New Schedule

1 day ago

Bilawal Bhutto Drops a Political Bombshell, Says Pakistan Needs a Major Reset

1 day ago

Latest

Bilawal Questions Pakistan’s System, But Who Will Question PPP’s 18-Year Rule in Sindh?

15 hours ago

Pakistani National or Iranian Agent? Man Behind Alleged Trump Assassination Plot Gets 27 Years

15 hours ago

Pakistani Group Acquires US Consul General’s Residence in Karachi for Rs6.92 Billion

16 hours ago

Gold Prices Crash to Lowest Level Since Sep 2025; Silver and Platinum Also Slide

17 hours ago

Middle East Tensions Fail to Stop Oil Price Decline as Brent Slips to $92.98

17 hours ago

Pakistan Forex Rates Today: Dollar, Pound, Euro and Riyal Prices Revealed

17 hours ago

MM Digital (Pvt.) Ltd.

MM News is a subsidiary of the MM Group of Companies. It was established in 2019 with the aim of providing people of Pakistan access to unbiased information. Contact Details: 03200201537

Quick Links

  • Home
  • Advertise
  • MM News Urdu
  • The Other Side-Pakistan
  • Contact Us
  • Privacy Policy

Top Pages

  • Latest News
  • Showbiz
  • OP-ED
  • Technology
No Result
View All Result
  • Latest News
  • National
  • Crime
  • Opinions

© Copyright 2024 MMNews - All Rights Reserved.